Zantac Users May Require Surgery To Repair A Valve In Their Esophagus

If one's heartburn continues after making dietary changes, it may be a sign of a serious problem requiring surgery

Wednesday, December 23, 2020 - Zantac, the world's most popular and effective heartburn and acid reflux medicine, was recalled by the FDA in 2020 over fears that the drug contained a chemical that could cause cancer. It is now believed that ranitidine is unstable and inherently multiplies to carcinogenic levels under normal conditions. Heartburn sufferers that can no longer access their medicine need to immediately consult their physician. Also, former Zantac users should change their diet to be more plant-based (fruits and vegetables) and avoid eating salt and spices, They should also stop drinking alcohol or coffee. When sufficient dietary changes are made, the heartburn should stop. If heartburn continues it is a sign that a more serious problem exists and that surgery may be required.

Heartburn left untreated may have more dramatic health consequences than failing to go to the doctor over fears of contracting the Coronavirus. The risks of serious illness or death from Covid-19 are confined to people who are elderly, morbidly obese, and have a pre-existing terminal illness like advanced-stage cancer, diabetes, or heart disease. Heartburn and acid reflux, on the other hand, could lead to cancer of the upper respiratory system starting in the lower esophagus up to the throat and mouth. Those organs have no protective lining against acids like the stomach has, hence the pain and discomfort. The pain and discomfort heartburn and acid reflux sufferers feel is stomach acid that has somehow come up through the esophageal sphincter and is burning the area in question. That burning many times leads to irritation that leads to developing cancer. Sanofi, the maker of Zantac, is under federal investigation into charges that the company knew for years that ranitidine (Zantac) was inherently unstable and could cause cancer. Zantac users may have developed cancer from taking the medicine regularly over many years. Some Zantac users have taken advantage of a free, no-cost, or obligation consultation with a Zantac Cancer Lawyer to see if they qualify to file a claim against Sanofi, Zantac's maker.

According to The Times Free Press, Walter Rose, M.D., a minimally invasive laparoscopic surgeon at CHI Memorial Surgical Associates, contributed to a piece that addresses the special needs of those who do not respond to dietary changes and continue to suffer heartburn. Dr. Rose tell readers that suffer from chronic, continuous heartburn called GERD, that they should consider surgery to alleviate their pain if all else has failed. Dr. Rose specializes in surgery that attempts to fix the valve that prevents stomach acid from entering the esophagus. "Surgery reinforces where the lower esophagus meets the stomach to keep acid where it belongs - in your stomach. Nearly all procedures for acid reflux are performed using minimally invasive techniques, meaning you can recover more quickly and get back to living your life faster than ever before."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.